Pharmaceutical Peptide CAS 12629-01-5 H GH 191aa Pure Humen Growth Hormone Powder For Muscle Growth

Pharmaceutical Peptide CAS 12629-01-5 H GH 191aa Pure Humen Growth Hormone Powder For Muscle Growth

Effects of growth hormone deficiency:

The clinical impact of growth hormone deficiency depends on the age at which the defect occurs. During adolescence, a period of peak height and sexu-al characteristics, deficiency of this hormone can lead to stunted growth and may require rhGH therapy to address the disease.

Growth hormone deficiency is very rare in adults, but GH levels begin to decline rapidly with age. However, in some cases, a complete loss of GH output may occur, which requires extensive testing to determine the cause and nature of the disease. Adults with growth hormone deficiency (GHD) tend to have a relative increase in fat mass, catabolism, or muscle tissue loss. Similarly, people with GHD may experience drowsiness and lower energy levels. These symptoms are usually reversed by the use of rhGH or GH-stimulating peptides such as Sermorelin, a GHRP designed to signal the hypothalamus to release growth hormone in pulses .

Early studies of GH replacement therapy in men over 60 years of age have shown increased muscle mass, decreased fat storage, and increased bone mineral density. While these results are encouraging, they do not in any way suggest that growth hormone can reverse the ageing process, and therefore cannot be technically labelled as an "anti-ageing" compound. Still, early adopters of the study seized on the concept and promoted GH replacement therapies to stop or even reverse the aging process.

In addition to the anti-aging studies on GH, several studies have been completed to evaluate the role of growth hormone in the treatment of neurological diseases such as multiple sclerosis, fibromyalgia, Crohn's disease and ulcerative colitis.

Related products:

Product Photos:

Certifications:

Company:

FAQ: